Health Information Management

Digest the new mandatory reporting requirements for ESA administration as of April 7

APC Payment Insider, April 1, 2008

This is an excerpt from a member only article. To read the article in its entirety, please login.

Don’t overlook these three must-read CMS publications

In January, CMS published three transmittals that present sizeable operational challenges when billing for erythropoietin stimulating agents (ESA)—drugs such as EPO, DPO, Epogen, Procrit, and Aranesp. The transmittals include:

Transmittal 1412, Change Request 5699

Transmittal 1413, Change Request 5818

Transmittal 80, Change Request 5818

Although facilities that provide end-stage renal disease (ESRD) treatments are already familiar with these guidelines, other hospitals may find that the coverage and billing requirements are unfamiliar and difficult to implement.

This is an excerpt from a member only article. To read the article in its entirety, please login.

Comments

0 comments on “Digest the new mandatory reporting requirements for ESA administration as of April 7

 

  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • Medical Records Briefing

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentaion can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Weekly Monitor

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular

Related Articles